Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ahmed Sadek, M.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ahmed Sadek's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ahmed Sadek has written about over time.
Adult, 1 publications between 2024 and 2024, average publication date April 2024. Aged, 1 publications between 2024 and 2024, average publication date April 2024. Aged, 80 and over, 1 publications between 2024 and 2024, average publication date April 2024. CA-125 Antigen, 1 publications between 2024 and 2024, average publication date April 2024. Female, 1 publications between 2024 and 2024, average publication date April 2024. GPI-Linked Proteins, 1 publications between 2024 and 2024, average publication date April 2024. Humans, 1 publications between 2024 and 2024, average publication date April 2024. Lung Neoplasms, 1 publications between 2024 and 2024, average publication date April 2024. Male, 1 publications between 2024 and 2024, average publication date April 2024. Mesothelioma, 1 publications between 2024 and 2024, average publication date April 2024. Middle Aged, 1 publications between 2024 and 2024, average publication date April 2024. Neoplasm Recurrence, Local, 1 publications between 2024 and 2024, average publication date April 2024. Pleural Neoplasms, 1 publications between 2024 and 2024, average publication date April 2024. Prospective Studies, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Sadek's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.